Author

Jialing Liu

Women's Hospital, School of Medicine, Zhejiang UniversityPrimary ORCID profile (0000-0003-4420-4382 · 5 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jialing LiuiD5 papers · San Francisco VA Medical Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Binyu ZhangiD· 1 shared Boxi Zhao· 1 shared Chunhao Long· 1 shared Guanyin Huang· 1 shared Hao YuiD· 1 shared Hui YangiD· 1 shared Jian Zhang· 1 shared Jianyang HuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Binyu ZhangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The HES1-SOD1 Antagonism Shapes Senescence Heterogeneity and Impacts Metastatic Relapse of Circulating Tumor Cells

Guanyin Huang, Xiaolong Xu, Binyu Zhang, Mao Zhao, Yixin Cheng, Boxi Zhao, Shuqian Zheng, Xuefei Liu, Songyan Yu, Liuyang Wang, Jianyang Hu, Chunhao Long, Yu Zhang, Yuling Sheng, Siyuan Xia, , Xin Hong

This study identifies two HES1-expressing senescent CTC subpopulations with distinct metabolic and clinical outcomes, showing HES1-SOD1 antagonism influences metastatic relapse.

bioRxiv · Aug 20, 2026 · PreprintCancer Biology